Resonant Capital Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1803236 Madison, WI

Position in REGN

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$308,652

-$78,440 QoQ

Shares Held

495

-1.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#940

of 1,322 holders

Holding Since

Mar 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Resonant Capital Advisors, LLC holds $2,648,282 across 5 Biotechnology names. REGN ranks #5 (11.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,726	$857,355
2	EXEL	Exelixis, Inc.	14,229	$774,199
3	INCY	Incyte Corp	3,410	$386,557
4	BMRN	Biomarin Pharmaceutical Inc	5,619	$321,519
5	REGN	Regeneron Pharmaceuticals, Inc. This page	495	$308,652

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$308,652	495	-1.2%	Shares	Sole	2026-07-27
2026-03-31	$387,092	501	+16.0%	Shares	Sole	2026-04-29
2025-12-31	$333,447	432	+19.0%	Shares	Sole	2026-01-29
2025-09-30	$204,104	363	-1.9%	Shares	Sole	2025-10-29
2024-09-30	$388,958	370	+6.3%	Shares	Sole	2024-10-18
2024-06-30	$365,758	348	+4.8%	Shares	Sole	2024-08-01
2024-03-31	$319,546	332	—	Shares	Sole	2024-05-01
No filing history on record for this holder in this stock.